Laksmidewi A. A. A. P, Putri Ni. L. P. D. S, Adnyana I M. O, Widyadharma I P. E. Cognitive Disorders with High Beta Amyloid Levels in Farmers using Organophosphate Pesticides. Biomed Pharmacol J 2020;13(1).
Manuscript received on :16-12-2019
Manuscript accepted on :21-02-2020
Published online on: 12-03-2020
Plagiarism Check: Yes
Reviewed by: Avtanski, Dimitar B  orcid publons
Second Review by: Dr. B. Surendiran orcid publons
How to Cite    |   Publication History
Views Views: (Visited 464 times, 1 visits today)   Downloads PDF Downloads: 349

Anak Agung Ayu Putri Laksmidewi , Ni Luh Putu Dirasandhi Semedi Putri, I Made Oka Adnyana  and I Putu Eka Widyadharma

Neurology Department, Faculty of Medicine, Sanglah Hospital, Bali, Indonesia

DOI : https://dx.doi.org/10.13005/bpj/1890

Abstract

One of the famous tourist destinations in Bali is Jatiluwih terrace rice in Tabanan regency, with beautiful rice paddies view. Many smallholders are exposed to chronic organophosphate due to the process of mixing pesticides, spraying, and cleaning in a minimum period of 2 years. This study used a consecutive case control plan for farmers who used chronic organophosphate pesticides in the village of Penarukan Kerambitan Tabanan from January to March 2019. A total of 66 study subjects aged 40-60 years were exposed to pesticides and met the eligibility criteria. This study showed subjects with serum beta amyloid levels of more than 112.03 ng/L had a 15 times risk of experiencing neurocognitive impairment compared to subjects with serum beta amyloid levels below 112.03 ng/L and statistically significant (95% CI 3.882- 60.969; p<0,001). 29 times at risk of causing neurocognitive dysfunction after adjusting for age, education and gender. The duration of exposure ≥ 10 years is at risk of causing neurocognitive impairment of 2.6 times compared to the duration of exposure of less than 10 years (95% CI 0.95-7.63; p=0.005).

Keywords

Organophosphate Pesticides; Amyloid Levels; Cognitive Disorders

Download this article as: 
Copy the following to cite this article:

Laksmidewi A. A. A. P, Putri Ni. L. P. D. S, Adnyana I M. O, Widyadharma I P. E. Cognitive Disorders with High Beta Amyloid Levels in Farmers using Organophosphate Pesticides. Biomed Pharmacol J 2020;13(1).

Copy the following to cite this URL:

Laksmidewi A. A. A. P, Putri Ni. L. P. D. S, Adnyana I M. O, Widyadharma I P. E. Cognitive Disorders with High Beta Amyloid Levels in Farmers using Organophosphate Pesticides. Biomed Pharmacol J 2020;13(1). Available from: https://bit.ly/2W4nLLX

Indroduction

One important sector in the Balinese economy is agriculture, but an increase in agriculture is correlated with an increase in the use of pesticides. Long-term exposure to pesticides has a negative impact on health and is thought to cause neurocognitive impairment.

Previous studies on animal models with the administration of deltamethrin and carbofuran once a day for a period of 28 days, reported a decrease in spatial memory function, decreased synaptic protein N-Methyl-D-Aspartate receptor 1 (NR 1), synaptophysin and synapsin 1, genes cAMP Related Element Binding (CREB) [1]. A meta-analysis study reported an association between exposure to chronic organophosphate pesticides and decreased neurocognitive function in workers [2].

Exposure to pesticides is thought to interfere with beta amyloid homeostasis, resulting in an increase in beta amyloid in the cortex and hippocampus resulting in memory impairment and decreased motor activity [3]. Oxidative stress causes an increase in the neuroinflamation response and progressive loss of neuronal cells and synapses. Exposure to pesticides also causes deposition of senile plaque beta amyloid protein in cerebral blood vessels associated with the incidence of dementia.

In this study it was reported that there is a risk of long-term use of organophosphate pesticides in farmers in the Kerambitan area of ​​Tabanan in the province of Bali with the risk of neurocognitive dysfunction especially memory and executives in chronic organophosphate pesticide users associated with serum beta amyloid levels.

Material and Methods

This study used a consecutive case-control design for farmers who were chronically exposed to organophosphate pesticides in Penarukan Kerambitan Tabanan village from January to March 2019.

This study was conducted on 66 subjects aged 40-60 years who were exposed to pesticides and met eligibility criteria. All research subjects were interviewed by the research team regarding demographic aspects, pesticide use activities, and neurocognitive function examinations were carried out.

Exposure to chronic pesticides in a minimum of 2 years with a history of direct exposure to pesticides through the process of mixing pesticides, spraying pesticides, when cleaning pesticide applicator [4]. Neurocognitive function is the ability to think and mentally which consists of five cognitive domains, namely attention, language, memory, visuospatial and executive functions. The neurocognitive function here is performed using a mini cog test. A mini cog test score of less than 3 indicates impaired neurocognitive function. A mini cog test score of more than or equal to 3 indicates normal neurocognitive function. The serum beta amyloid level was measured by taking a blood sample of 2 milliliters and collected in a bottle with anti-coagulant ethylenediaminetetraacetic acid (EDTA). The examination method uses the Enzyme-Linked Immunosorbent Assay (ELIZA) system with a 470 reader 270 Biomerieux washer in 2002 in the Clinical Pathology laboratory of Sanglah Central General Hospital. Serum beta amyloid levels were assessed in units of ng / L. Determination of the limit of normal serum beta amyloid levels was done statistically using the Receiver Operating Characteristic (ROC) method and assessing the Area Under the Curve (AUC) method. The threshold value of serum beta amyloid levels used in this study was 112.03 ng/L with a sensitivity of 90% and specificity of 70%. Groups with high serum beta amyloid levels (≥112.03 ng/L) and groups with normal serum beta amyloid levels (<112.03 ng/L). Data analysis using SPSS version 21.0 for Windows includes descriptive analysis, bivariate analysis to calculate Odds Ratio (OR), with statistical significance determined based on the p value, declared significant if p<0.05, and multivariate analysis.

Results

This study used 66 research subjects which were then classified into two groups, namely impaired neurocognitive function (case group) and normal neurocognitive function (control group). Research subjects were dominated by women (n=40; 60.6%) and most of the study subjects were 60 years old (n=26; 39.4%). Fifty-nine percent of research subjects with educational background graduated from elementary school. Most research subjects do not smoke and do not consume alcohol. Exposure to chronic organophosphate pesticides is the length of exposure to pesticides obtained during life. Mini cog aims to evaluate neurocognitive function globally and obtained a range of scores between 1 to 5. The range of serum beta amyloid levels is quite wide, which is between 49.24 ng/L – 3035.90 ng/L. The basic characteristics of the research subjects are presented in table 1.

Table 1: Participants Characteristics

Characteritics

Cases Controls
n (%)
Age (years) 60 (40-60) 54 (40-60)
Gender

 

Male

Female

12 (36.4)

21 (63.6)

14 (42.4)

19 (57.6)

Education (years) 6 (0-12) 6 (0-12)
Exposure (years) 15 (5-40) 5 (2-15)
Mini Cog Score 2 (1-2) 3 (3-5)
Serum Beta Amyloid Levels (ng/L)

 

160,25

(79.94-3035.90)

109.88

(49.24-156.79)

The relationship between each demographic characteristic of the study subjects and neurocognitive function is presented in table 2. The age variable uses a 55-year cut point determined based on the median value of all study subjects. The analysis showed the OR value of age was 0.371 with a significance value that was not significant. The gender variable showed an OR of 0.776 with a significance value that was not significant. Educational variables, smoking, and alcohol also did not show significant significance in influencing neurocognitive function.

Table 2: Relationship of Subjects Characteristics to Cognitive Function

Characteristics

Cases Controls OR

(95% CI)

p-value
n(%)
Age (years)   < 55

≥ 55

13 (39.4)

20 (60.6)

21 (63.6)

12 (36.4)

0.371

(0.137-1.005)

0.084
Gender Male

Female

12 (36.4)

21 (63.6)

14 (42.4)

19 (57.6)

0.776

(0.288-2.087)

0.614
Education (years)

 

≤ 6

> 6

27 (81.8)

6 (18.2)

20 (60.6)

13 (39.4)

2.925

(0-948-9.028)

0.057
Smoking

 

Yes

No

7 (21.2)

26 (78.8)

7 (21.2)

26 (78.8)

1.00

(0.307-3.255)

0.805
Alcohol

 

Yes

No

2 (6.1)

31 (93.9)

2 (6.1)

31 (93.9)

1.000

(0.132-7.555)

1.000*

*tested with Fisher’s exact; OR= odds ratio

The ROC curve showed that the serum beta amyloid level had an AUC value obtained at 88.9% (95% CI 0.806-0.972, p<0.001). The results of the ROC coordinates showed the threshold value of the serum beta amyloid level used in this study was 112 , 03 ng/L with a sensitivity of 90% and specificity of 70%. Research data were classified into groups with high serum beta amyloid levels (≥112.03 ng/L) and groups with normal serum beta amyloid levels (<112.03 ng/L). The relationship of serum beta amyloid levels with organophosphate exposure is shown in table 3. The analysis showed that exposure to lama 10 years risk of causing neurocognitive impairment of 2.6 times compared to the duration of exposure less than 10 years (95% CI 0.95-7.63; p=0.005).                          * OR= odds ratio

Table 3: The Relationship Between Chronic Organophosphate Exposure and Serum Beta Amyloid Levels

Characteristics

Beta amyloid levels (%) OR

(95% CI)

p-value
High Low
Peticides exposure  ≥ 10 years

< 10 years

29 (67.4)

14 (32.6)

10 (43.5)

13 (56.5)

2.693

(0.95-7.63)

0.005

Amyloid Levels

The relationship of serum beta amyloid levels with neurocognitive function is presented in table 4. The results of the analysis showed subjects with serum beta amyloid levels of more than 112.03 ng/L had a 15-fold risk of causing neurocognitive impairment compared to subjects with serum beta amyloid levels below 112.03 ng/L and statistically significant (95% CI 3,882-60,969; p<0.001).

Table 4: Relationship of Beta Serum Amyloid Levels with Neurocognitive Function

Characteristics

Cases Controls OR

95% CI

p-value
n (%)
Serum Beta Amyloid Levels (ng/L)

High      Normal

30 (69.8)

3 (13.0)

13 (30.2)

20 (87.0)

15.3

(3.882-60.969)

<0.001

* OR= odds ratio

Variables included in multivariate analysis were duration of exposure to pesticides, serum beta amyloid levels, age, and education. Based on the results of multivariate analysis the variables that influence neurocognitive function are serum beta amyloid levels with adjusted OR values of 29.581, p <0.001 95% CI 4.754-184.046 and duration of pesticide exposure with adjusted OR values of 21.514, p<0.001 95% CI 4.219-109.707.

Discussion

This study shows that the proportion of male and female study subjects who experienced neurocognitive impairment compared to subjects without neurocognitive impairment showed no clinical significance. The relationship between age and neurocognitive function has been proven theoretically. Based on this the age of the subjects in this study was made to be homogeneous and limited to 40 to 60 years to reduce the possibility of bias in the analysis process. The difference between the gender between cases and controls was not clinically significant. Educational variables that are clinically significant affect neurocognitive function but are not statistically significant. This result is also supported by previous studies which showed that the level of education was not significantly significant in pesticide users in influencing neurocognitive function [5].

The duration of exposure received by research subjects throughout their lives varied from 2 years to 40 years with an average duration of exposure of 12.98 years. The duration of organophosphate pesticide exposure of more than or equal to 10 years significantly increases the risk of serum beta amyloid levels by 2.6 times (95% CI 0.95-7.63; p=0.005).

An in vivo study in 2011, found that organophosphate exposure can cause metabolic disorders related to amyloid-β homeostasis, thereby causing an increase in amyloid-β levels in the cortex and hippocampus [3]. Organophosphate exposure also causes deposition of amyloid β senile plaque protein in cerebral blood vessels so that it is responsible for causing dementia [6].

Another study in 2019 by Jaymie et al. in rats given organophosphate exposure for eight months the results of high beta amyloid levels were found in the cortex and hippocampus area. This increase was significant in the two types of beta amyloid both A1-40 and A1-42 in the cortex and beta amyloid A1-42 in the hippocampus.

The pathophysiology of organophosphate exposure causing an increase in beta amyloid levels has not been described in many previous studies. Organophosphate compounds induce the formation of free radicals through increased oxidative stress. Amyloid beta protein was found to increase with increasing oxidative stress. Exposure to chronic organophosphate pesticides triggers the formation of reactive oxygen and nitrogen, then damages the neuronal cell lipid membrane and changes the composition of the neuron cell lipid membrane. In addition, chronic organophosphate exposure also causes iron metal accumulation through the Fenton reaction and subsequently is involved in the formation of free radicals [7].

Increased oxidative stress will trigger the formation of beta amyloid protein and vice versa aggregation of beta amilod protein will increase oxidative stress through increased levels of lipid peroxidation products including malondialdehyde, 4-hydroxynonenal (HNE) and acrolein [8]. These toxic products are formed as a result of changes in the cellular structure of neuron cells due to an increase in oxidative stress [7]. Increased formation of free radical species results in an imbalance of apoptotic proteins namely Bax protein and anti-apoptotic Bcl-2, Bcl-xL which alter the composition of the mitochondrial membrane and facilitate the release of cytochrome C and activation of neuronal apoptotic pathways [9].

Chronic organophosphate exposure will activate glia cells, macrophages, and oligodendrocytes thus triggering an inflammatory response. Activation of these cells then triggers the release of pro-inflammatory cytokines in the brain, such as interleukin (IL) -1β, IL-18 and IL-33. The release of proinflammatory cytokines will then facilitate the formation and deposition of beta amyloid [10].

The pathophysiology of beta amyloid causing neurocognitive impairment has been described. Amyloid beta is a major component of amyloid plaque, a plaque found in patients with Alzheimer’s, dementia Lewy bodies as well as other dementias [11]. Beta amyloid can also form aggregates that line blood vessels in the brain called amyloid cerebral angiopathy [12,13].

Beta amyloid formed after successive division of APP (Amyloid Protein Precursor). The increase in APP results in a number of neuritic plaques, slows the learning process and shows memory impairment in line with an increase in the amount of amyloid. The anatomical pathology of beta amyloid in humans and rats is no different, namely there is an aggregation of beta peptide amyloid which is hydrophilic 38-43 amino acids. Most beta amyloid is found in the frontomedial cortex, hippocampus and enthorinal cortex as well as the occipital cortex region [14].

The results of this study showed subjects with high serum beta amyloid levels had a 15 times risk of causing neurocognitive impairment. This is consistent with previous research by Harrington et al. in 2017 in 335 subjects aged 60-85 years. All subjects were positron emission tomography (PET) scans and neurocognitive function examinations followed for 72 months. Subjects were categorized as Aβ +, ie the value of SUVR / Before the Centiloid Kernel Transformation ≥1.5 based on PET scan results and Aβ−, namely the value of SUVR / Before the Centiloid Kernel Transformation <1.5. The results of this study indicate the Aβ + group has a longer response time in completing the attention function and processing speed checks.

A 54-month hospital-based cohort study conducted by Pietrzak et al. in 2014 in 333 healthy adults. This study aims to determine changes in beta amyloid evaluated by PET scans associated with changes in neurocognitive function. This study concludes that an increase in beta amyloid levels is associated with cognitive decline globally (Cohen’s value d=0.78, 95% CI 0.33-1.23), language (Cohen’s value d=0.51, 95% CI 0.07-0.96), and executive function (Cohen’s value d=0.39, 95% CI 0.05-0.83).

Another study also evaluated the relationship between beta amyloid levels and neurocognitive function in normal individuals. The study was conducted on 907 individuals aged over 40 years. The results of this study obtained a correlation between positive beta amyloid (beta amyloid levels in cerebrospinal fluid or on abnormal PET scans) with a decrease in delayed memory function and immediate memory (Auditory Verbal Learning Test), attention and executive functions (Trail Making Test A and B) [15].

Conclusion

The study concluded that exposure to chronic organophosphate pesticides for more than 10 years, 2.6 times the risk of causing high serum beta amyloid levels. Subjects with serum beta amyloid levels of more than 112.03 ng/L had 15 times the risk of causing neurocognitive impairment or 29 times the risk of causing neurocognitive impairment after adjusting for age, education, and gender.

Conflict of Interest

There were no financial supports or relationship between authors and any organization that could pose any conflict of interests in this article.

Acknowledgments

None

References

  1. Li G, Kim C, Kim J, Yoon H, Zhou H, Kim J. Common pesticide, dichlorodiphenyltrichloroethane (DDT), increases amyloid-β levels by impairing the function of ABCA1 and IDE: implication for Alzheimer’s disease. J Alzheimers Dis. 2015;46(1):109–122.
  2. Muñoz-Quezada MT, Lucero BA, Iglesias VP, Muñoz MP, Cornejo CA, Achu E, et al. Chronic exposure to organophosphate (OP) pesticides and neuropsychological functioning in farm workers: a review. Int J Occup Environ Health. 2016;22(1):68–79.
  3. G Salazar J, Ribes D, Cabre M, L Domingo J, Sanchez-Santed F, Teresa Colomina M. Amyloid β peptide levels increase in brain of AβPP Swedish mice after exposure to chlorpyrifos. Curr Alzheimer Res. 2011;8(7):732–740.
  4. Ministry of Health. Peraturan Menteri Kesehatan Nomor 1350/Menkes/SK/XII/2001 tentang Pestisida. 2011.
  5. Corral SA, de Angel V, Salas N, Zúñiga-Venegas L, Gaspar PA, Pancetti F. Cognitive impairment in agricultural workers and nearby residents exposed to pesticides in the Coquimbo Region of Chile. Neurotoxicol Teratol. 2017;62:13–19.
  6. Saravi SSS, Dehpour AR. Potential role of organochlorine pesticides in the pathogenesis of neurodevelopmental, neurodegenerative, and neurobehavioral disorders: A review. Life Sci. 2016;145:255–264.
  7. Hardas SS, Sultana R, Clark AM, Beckett TL, Szweda LI, Murphy MP, et al. Oxidative modification of lipoic acid by HNE in Alzheimer disease brain. Redox Biol. 2013;1(1):80–85.
  8. Poli G, Schaur JR. 4-Hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life. 2000;50(4–5):315–321.
  9. Zhou F, Yang Y, Xing D. Bcl-2 and Bcl-xL play important roles in the crosstalk between autophagy and apoptosis. FEBS J. 2011;278(3):403–413.
  10. Sunkaria A, Wani WY, Sharma DR, Gill KD. Dichlorvos exposure results in activation induced apoptotic cell death in primary rat microglia. Chem Res Toxicol. 2012;25(8):1762–1770.
  11. Whitehead SN, Hachinski VC, Cechetto DF. Interaction between a rat model of cerebral ischemia and β-amyloid toxicity: inflammatory responses. Stroke. 2005;36(1):107–112.
  12. Smith EE, Greenberg SM. β-Amyloid, blood vessels, and brain function. Stroke. 2009;40(7):2601–2606.
  13. Weller RO, Preston SD, Subash M, Carare RO. Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease. Alzheimers Res Ther. 2009;1(2):6.
  14. Calhoun ME. Mouse models of cognitive aging: Behavioral tasks and neural substrates. In: Animal Models of Human Cognitive Aging. Springer; 2009. p. 1–10.
  15. Bos I, Vos SJ, Jansen WJ, Vandenberghe R, Gabel S, Estanga A, et al. Amyloid-β, Tau, and Cognition in Cognitively Normal Older Individuals: Examining the Necessity to Adjust for Biomarker Status in Normative Data. Front Aging Neurosci. 2018;10:193.
Share Button
(Visited 464 times, 1 visits today)

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.